Alex Gorsky | |
---|---|
Born | 1960 (age 63–64) [1] Kansas City, Kansas, U.S. |
Education | United States Military Academy (BS) University of Pennsylvania (MBA) |
Years active | 1988–2022 |
Spouse | Patricia Gorsky |
Children | 1 |
Alex Gorsky (born 1960) is an American businessman. He is the former chairman and CEO of Johnson & Johnson. Gorsky stepped down as CEO of Johnson & Johnson in January 2022 and was succeeded by Joaquin Duato. He was the seventh person who served as the company's chairman and chief executive officer since it became a publicly traded company in 1944. He is a board director of Apple [2] and JP Morgan Chase. [3]
Gorsky's grandparents immigrated to the United States from Russia and Croatia. Gorsky was born the third of six children of Albert and Loretta (née Bartolac) Gorsky [4] in Kansas City, Kansas. [5] When he was 12, his family moved to Fremont, Michigan, [1] where his father, a Korean War veteran, took a job as a marketing executive for Gerber Foods. [1] In high school, Gorsky was captain of the varsity football team, assuming positions as quarterback and linebacker. [1] He was also captain of the swimming team. [1]
In 1977, as a member of Boy's State, Gorsky was chosen to represent Michigan at the Boy's Nation national conference. [6] In the same year, Congressman Guy Vander Jagt nominated Gorsky to attend the United States Military Academy at West Point. In 1981, Gorsky was one of the cadets chosen for the Army Ranger School where he earned a Ranger Tab. [7] In May 1982, when Gorsky graduated from West Point with a Bachelor of Science degree, he joined the Artillery Branch of the U.S Army. As lieutenant at the age of 22, he led an artillery platoon. [8] After six years as an officer, serving in Europe and Panama, he became captain in 1987. In 1988, Gorsky married Patricia Dittrich, a hospital nurse in Carmel, California. Gorsky left the Army in 1988. [5]
Gorsky earned his Master of Business Administration from The Wharton School at the University of Pennsylvania in 1996. [1]
Gorsky joined Johnson & Johnson in 1988 as a sales representative in its pharmaceutical business unit, Janssen Pharmaceuticals. [1] He held various management and leadership roles at Janssen before becoming Company Group Chairman overseeing Europe, Middle East, and Africa in 2003. [5]
Gorsky led the marketing of products such as Risperdal. Ultimately Johnson & Johnson was fined $2.2 billion for strategies that downplayed the drug's side effects, encouraged off-label use, and provided kickback payments to Omnicare, a company that provided drug services to nursing homes. [9]
Gorsky joined the Novartis Pharmaceuticals Corporation in 2004 as chief operating officer and head of General Medicines. In 2005, he was appointed Head of Pharmaceuticals North America and Chief Executive Officer. [10] During his tenure, he created the CEO Diversity & Inclusion Award. He oversaw the growth of its cardiovascular and other franchises. [11]
Gorsky returned to Johnson & Johnson in 2008 when he was appointed company group chairman for Ethicon, Inc. In September 2009, he was promoted to worldwide chairman, medical devices & diagnostics. Then-CEO William C. Weldon chose Gorsky to be vice chairman in the Office of the Chairman. [12] On April 26, 2012, Gorsky was appointed Chief Executive Officer. On December 28, 2012, Gorsky was appointed chairman of the board. A longtime advocate of diversity and inclusion, Gorsky was named one of the "100 Most Inspiring Leaders" by Pharma Voice. [12] [13]
Gorsky oversaw the company's legal defense against talc class action suits and opioid lawsuits. In January 2020, Gorsky testified at the New Jersey trial about Johnson & Johnson's baby powder product. [14]
Under Gorsky's leadership, the company stock more than tripled, and averaged more than a 15% annual return, surpassing the S&P 500. Johnson & Johnson's market capitalization went from nearly $180 billion to more than $470 billion. [15]
"As the world's largest health care company, we are bringing to bear our best scientific minds, and rigorous standards of safety, in collaboration with regulators, to accelerate the fight against this pandemic," Gorsky said in New Jersey Business magazine in 2020. Gorsky attributed the strong multilayered immune response from J&J's vaccine to its innovative adenovirus-vector platform, AdVac, which it has developed over a decade. [16]
Gorsky was the executive sponsor of the J&J Women's Leadership Initiative and the Veteran's Leadership Council. [17] In 2021, with a salary of $23.14 million, he ranked second on the list of highest-paid CEOs in healthcare, according to Becker's Hospital Review. [18]
Gorsky was the speaker at The Wharton School at the University of Pennsylvania 2022 MBA Graduation Ceremony. [19]
Gorsky is a member of The Business Council's executive committee [20] and served as the chair of the Business Roundtable Corporate Governance Committee. [21] Since 2014, Gorsky has been on the board of directors at IBM. [22] [23] Gorsky is a board member at Apple, Inc., [24] JPMorgan Chase, [25] and the National Academy Foundation. [26] He is on the advisory board at Thayer Leader Development Group at West Point, [27] and is Co-Chair of the Strategic Investor Initiative (SII) advisory board at Chief Executives for Corporate Purpose (CECP). Gorsky is a member of the Bipartisan Policy Center's CEO Council on Health and Innovation and of The Wharton Leadership Advisory Board. [28] Gorsky is vice chairman of the Travis Manion Foundation. [17] Gorsky was on the American Manufacturing Council, [29] [30] and was a member of the American Heart Association CEO Roundtable. [31]
Johnson & Johnson (J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Its common stock is a component of the Dow Jones Industrial Average, and the company is ranked No. 40 on the 2023 Fortune 500 list of the largest United States corporations. In 2023, the company was ranked 40th in the Forbes Global 2000. Johnson & Johnson has a global workforce of approximately 130,000 employees who are led by the company's current chairman and chief executive officer, Joaquin Duato.
James Edward Burke was an American businessman who was the chief executive officer (CEO) of Johnson & Johnson (J&J) from 1976 to 1989, where he worked for forty years. The company's revenue tripled to more than $9 billion under his tenure.
Harold Whittlesey "Terry" McGraw III is an American businessman and is the chairman emeritus of McGraw Hill Financial.
Fred Hassan, is a Pakistan-born American business executive who works for Warburg Pincus and was CEO of three global pharmaceutical companies.
Robert Wolf is the former Chairman and CEO of UBS Americas as well as the president and chief operating officer of UBS Investment Bank.
Sherilyn S. McCoy is an American scientist and business executive. She is the former CEO of Avon Products and former vice chairman and member of the office of the chairman of Johnson & Johnson, where she was responsible for the pharmaceutical and consumer business divisions of the company. She was appointed as the vice chairman in January 2011, after which she was named by Fortune Magazine, as the 10th woman on their list of "50 Most Powerful Women in Business", a list on which she has been included since 2008. In February 2012, she resigned her employment with Johnson & Johnson after 30 years and was subsequently named as the CEO of Avon Products. In August 2012, she was recognized as the 39th most powerful woman in the world by Forbes Magazine.
Chris Viehbacher is a German-Canadian businessman. He served as the Chief Executive Officer of Sanofi and Chairman of Genzyme until 29 October 2014. Viehbacher then worked with Gurnet Point Capital, a healthcare venture capital and private equity fund backed by Ernesto Bertarelli and his family.
Robert A. Bradway is an American businessman. He is the chairman and chief executive officer of Amgen.
Jeff Aronin is an American investor, entrepreneur, and biotechnology executive. He is founder, chairman and CEO of Paragon Biosciences, LLC, a global life science company that creates, builds, and funds innovative biology-based companies.
Joseph Robert Swedish is an American healthcare executive and leader. He is a former senior adviser to the board of directors at Anthem, Inc., a Fortune 29 company, and was the CEO of Anthem, Inc. from 2013 to 2017. For 12 years in a row Swedish was named Modern Healthcare’s one of the 100 Most Influential People in Healthcare.
Bruce Dale Broussard is an American business executive. From 2013 to 2024, Broussard served as Chief Executive Officer of Humana, a healthcare company with headquarters in Louisville, Kentucky. Prior to joining Humana, he served in several executive roles, including chief executive office of McKesson Specialty/US Oncology.
Sandi Peterson is an American businesswoman. She is currently an Operating Partner at Clayton, Dubilier & Rice and serves on the Microsoft Board of Directors. She was group worldwide chairman at Johnson & Johnson from 2012-2018 and previously held leadership positions at Bayer Medical Care, Medco Health Solutions, Nabisco and Whirlpool Corporation.
Donato J. Tramuto is an American healthcare executive, global health activist, and author. He is the former CEO of Tivity Health and has held executive positions for i3 and Physicians Interactive. Tramuto is also the founder of The TramutoPorter Foundation and a nonprofit program, Health eVillages, that provides curated medical information to clinicians in remote areas. He previously served as elected Board of Selectmen for the Town of Ogunquit and has authored three books, including The Double Bottom Line: How Compassionate Leaders Captivate Hearts and Deliver Results.
John L. Flannery is an American business executive. He succeeded Jeff Immelt as the eleventh CEO and tenth chairman of General Electric, and was CEO from August 2017 until October 2018. Prior to ascending to the CEO role, Flannery held leadership roles inside GE for nearly 30 years, heading GE Healthcare, GE India and other business units.
Harvey J. Berger is an American physician-scientist, entrepreneur and biotechnology executive. He was the founder and chairman and chief executive officer of ARIAD Pharmaceuticals, Inc. for 25 years, starting in 1991 and became advisor to the board in 2016. He was also executive chairman at Medinol, Inc from 2017 to 2018. In February 2018, Berger was appointed to the Dana–Farber Cancer Institute Board of Trustees.
Jeffrey Leiden is an American physician, scientist and businessman who is the executive chairman of Vertex Pharmaceuticals, a biotechnology company based in Boston, Massachusetts. He was initially appointed to the board of directors of the company in 2009 and was CEO and president from February 2012 to March 2020.
Albert Bourla is a Greek-American veterinarian and businessman known for serving as the chairman and chief executive officer of the pharmaceutical company Pfizer. He joined the company in 1993 and has held several executive roles across Pfizer's divisions. Prior to becoming chief executive officer, Bourla was chief operating officer.
Karen S. Lynch is an American businesswoman and the president and chief executive officer of CVS Health. Lynch serves on the board of directors of AHIP, CVS Health, and U.S. Bancorp. In 2015, she became the first female president of Aetna. She has held executive positions at Magellan Health Services and Cigna. In 2021, she became the highest-ranking female chief executive on the Fortune 500 list. She currently serves as a member of the President's Export Council, The Business Council, the Business Roundtable, and other organizations.
Joaquin Duato is a Spanish-American business executive. Duato is a dual citizen of Spain and the United States. He is the chairman and chief executive officer (CEO) of Johnson & Johnson, an American multinational conglomerate. He is the eighth person to be CEO of Johnson & Johnson since it became a publicly-traded company in 1944.
{{cite news}}
: CS1 maint: multiple names: authors list (link)